OSLO, NORWAY: PCI Biotech, a Norwegian cancer focused biopharmaceutical company and MDimune Inc., a private South Korean biotech company developing innovative drug delivery technologies for modifying cellular and disease processes in many areas of human disease, announced a preclinical research collaboration that would offer several opportunities for future development. Commenting on the announcement, Per Walday,…
All posts tagged PCI Biotech
PCI Biotech forms research collaboration with DCprime
OSLO: PCI Biotech has announced an extensive research collaboration. Within the collaboration, DCprime and PCI Biotech will combine their know-how and technology platforms to pursue the development of novel cancer vaccination concepts based on tumour-independent antigens (TIAs). PCI Biotech is a biopharmaceutical late stage clinical development company focusing on development and commercialisation of novel therapies …